These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 17607721)
1. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721 [TBL] [Abstract][Full Text] [Related]
2. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163 [TBL] [Abstract][Full Text] [Related]
3. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597 [TBL] [Abstract][Full Text] [Related]
4. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related]
7. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560 [TBL] [Abstract][Full Text] [Related]
8. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. O-Charoenrat P; Khantapura P Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576 [TBL] [Abstract][Full Text] [Related]
10. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837 [TBL] [Abstract][Full Text] [Related]
11. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
12. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818 [TBL] [Abstract][Full Text] [Related]
14. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Gao LB; Liang WB; Xue H; Rao L; Pan XM; Lv ML; Bai P; Fang WL; Liu J; Liao M; Zhang L Clin Chim Acta; 2009 Nov; 409(1-2):132-5. PubMed ID: 19758567 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related]
17. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Wei YS; Lan Y; Luo B; Lu D; Nong HB Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899 [TBL] [Abstract][Full Text] [Related]
18. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229 [TBL] [Abstract][Full Text] [Related]
19. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464 [TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]